Pursuant to the Ljubljana Stock Exchange Rules and other applicable regulations, SALUS, Ljubljana, d.d., is publishing for the first time an English version of the Audited Consolidated Annual Report of the SALUS Group and SALUS, Ljubljana, d.d. for the year 2025.

International growth, international reporting

SALUS Group is one of the leading independent pharmaceutical commercialization and distribution platforms in the CEE region, supporting biotech, pharmaceutical, and MedTech companies seeking a trusted regional partner to enter, expand, or strengthen their presence across 18 CEE markets.

As the Group grows across Central and Eastern Europe, so does the circle of those following its performance from the outside. Among them is a growing number of international investors and analysts with an interest in the SALR share. Publishing the Annual Report in English is therefore an important milestone for the Group, as the full picture of our business becomes accessible to the international financial community for the first time. The Company will provide its financial reporting in English going forward, starting with the 2025 Annual Report.

The report will also be available on the Company's website at www.salus.eu.

This announcement will be available on the website of SALUS, Ljubljana, d.d. from 7 August 2026 until the expiry of the legally prescribed publication period.